Background. Tuberculous meningitis (TBM) research is hampered by low numbers of microbiologically confirmed TBM cases and the fact that they may represent a select part of the disease spectrum. A uniform TBM research case definition was developed to address these limitations, but its ability to differentiate TBM from bacterial meningitis has not been evaluated.
Tuberculosis continues to pose a major global health challenge with a high morbidity and mortality, despite effective antituberculosis medication, in tuberculosisendemic areas [1, 2] . Tuberculous meningitis (TBM) is the most devastating manifestation of tuberculosis and is generally associated with poor outcomes. Diagnosis is often delayed due to the nonspecific nature of early symptoms such as cough, weight loss, fever, vomiting, and lethargy. With disease progression, a more definitive clinical picture becomes manifest [3] ; however, early treatment initiation is critical to optimize outcome [4, 5] .
Identification of Mycobacterium tuberculosis in cerebrospinal fluid (CSF) provides bacteriological confirmation of TBM. Unfortunately, due to the paucibacillary nature of TBM, CSF microscopy for acid-fast bacilli (AFB) [6] and CSF culture for M. tuberculosis has low sensitivity (<20% and <50%, respectively) [3, 7, 8] compared with clinical criteria. Although culture provides the accepted "gold standard," it has little clinical utility as it takes up to 42 days to confirm a positive result. A meta-analysis of the accuracy of commercial nucleic acid amplification tests (NAATs) for the diagnosis of TBM, mostly adult studies, showed a sensitivity of 64% and specificity of 98% compared with culture [9] .
Thus it may serve as a rapid "rule-in" test, but does not provide a reliable "rule out" test.
TBM research is greatly hampered by the absence of reliable diagnostic criteria and standardized approaches [10] . A recent review found that existing trials assessing antituberculosis treatment for TBM had limited power and poor methodology and used varying treatment regimens with conflicting results [11] . Answering critical research questions will require multicenter randomized controlled trials using standardized diagnostic and staging criteria, with sufficient patient numbers to demonstrate differences in outcome [11] . Because it is difficult to obtain adequate sample sizes using only culture-confirmed TBM cases, inclusion of probable and possible TBM cases requires consideration.
A uniform research case definition for TBM in adults and children was developed to improve standardization of diagnosis for research purposes [12] . Classification as definite, probable, or possible TBM is based on a composite score of clinical findings and special investigations (see Table 1 ). Individual criteria and their relative weights were assigned based on an extensive literature review together with international expert consensus [12] [13] [14] [15] [16] [17] . The accuracy of proposed criteria for probable and possible TBM has not been assessed. Our study aimed to evaluate the diagnostic performance of probable and possible TBM criteria in children with culture-confirmed TBM and cultureconfirmed bacterial meningitis.
PATIENTS AND METHODS
We conducted a retrospective review of all children (<13 years of age) treated for TBM between January 1985 and April 2005 at Tygerberg Children's Hospital, Cape Town, South Africa. Clinical data were prospectively collected in all TBM patients as part of ongoing studies conducted at the time. For comparative purposes, we identified a group of children (<13 years of age) with culture-confirmed bacterial meningitis, diagnosed between January 2003 and November 2009. Bacterial meningitis cases were identified from the National Health Laboratory Service database at Tygerberg Children's Hospital; relevant clinical data were retrieved from patient files. The study was approved by the Human Research Ethics Committee of Stellenbosch University (reference number N10/11/367).
CASE DEFINITIONS

Tuberculous Meningitis
Patients were classified as "definite TBM" if the CSF culture was positive for M. tuberculosis; smear microscopy for AFB and/or commercial NAAT testing was not performed at the time.
Identification of probable and possible TBM was based on predefined diagnostic scoring criteria (Table 1 ) [12] . Points were allocated in the following categories: (1) clinical findings, (2) CSF results, (3) neuroimaging findings, (4) evidence for tuberculosis outside the central nervous system, and (5) additional laboratory criteria. A total score of at least 12 was compatible Possible TBM = total score of 6-11 when neuroimaging available = total score of 6-9 when neuroimaging unavailable Source: Marais et al [12] .
Abbreviations: AFB, acid-fast bacilli; CNS, central nervous system; CSF, cerebrospinal fluid; CT, computed tomography; IGRA, interferon-γ release assay; MRI, magnetic resonance imaging; NAAT, nucleic acid amplification test; TBM, tuberculous meningitis; TST, tuberculin skin test; US, ultrasound.
with probable TBM (when neuroimaging was unavailable, the total score was reduced to at least 10), whereas a total score of 6-11 equated to a possible TBM diagnosis (when neuroimaging was unavailable, the total score required was reduced to 6-9), with a minimum number of points coming from CSF or neuroimaging criteria. Potential alternative causes had to be excluded by performing at least (1) CSF Gram stain and bacterial culture and (2) CSF India ink stain, cryptococcal antigen latex agglutination test, and/or cryptococcal culture. These investigations were routinely performed. Additional investigations such as (3) viral culture and/or polymerase chain reaction (PCR) and tests to exclude (4) neurosyphilis and (5) cerebral malaria should be conducted if clinically or epidemiologically indicated; these investigations were not routinely performed in our cohort. Due to the retrospective nature of the study, the following imaging criteria could not be evaluated: precontrast basal hyperdensity on computed tomography (CT) and imaging of tuberculosis outside the central nervous system (apart from standard posteroanterior and lateral chest radiographs). TBM disease staging was determined as follows: stage I, Glasgow Coma Scale (GCS) of 15 and no focal neurological signs; stage IIa, GCS of 15 plus focal neurological signs; stage IIb, GCS of 11-14 plus focal neurological signs; and stage III, GCS <11 [17, 18] .
Bacterial Meningitis
A diagnosis of definite bacterial meningitis was made if bacterial pathogens were identified by Gram stain and/or culture from CSF, and patients were treated for bacterial meningitis.
Statistical Analysis
Statistical analysis was done using SPSS version 20 (SPSS Inc, Chicago, IL) and SAS version 9.1 (SAS Institute Inc, Cary, NC). The Fisher exact test and odds ratios (ORs) were used in univariable analyses comparing "definite TBM" and "definite bacterial meningitis," using a 2-tailed test for statistical significance.
RESULTS
In total, 554 children were treated for TBM during the study period; 66 (11.9%) were classified as definite TBM, 408 (73.6%) as probable TBM, and 72 (13.0%) as possible TBM; 8 had insufficient information for reliable classification [12] . Table 2 When scoring children with definite TBM independent of their M. tuberculosis culture results, 57 of 66 (86%) scored as probable TBM and 9 of 66 (14%) as possible TBM. Of the 9 culture-confirmed TBM cases that scored as "possible" TBM, 3 had limited clinical symptoms (1 was TBM stage I and the other 2 were TBM stage IIa) and 6 had minimal signs on neuroimaging. Seven culture-confirmed TBM cases were within 2 points of the cutoff for a "probable" TBM score; the remaining 2 patients had low scores for both clinical and neuroimaging criteria.
Among the definite bacterial meningitis group, 18 of 32 (56%) scored as unlikely TBM and 14 of 32 (44%) as possible TBM. Comparing patients with definite TBM and definite bacterial meningitis, a probable TBM score provided good diagnostic accuracy (sensitivity 86% and specificity 100%). A possible TBM score was more sensitive but very nonspecific (sensitivity 100% and specificity 56%). Table 3 summarizes findings for specific criteria on univariate analysis. Comparing definite TBM to definite bacterial meningitis, the most informative clinical criteria were either weight loss or persistent cough >2 weeks (OR, 27.5; 95% confidence interval [CI], 3.5-213.1), recent close tuberculosis contact or positive tuberculin skin test (OR, 15.0; 95% CI, 3.3-67.9), and focal neurological deficit (OR, 15.0; 95% CI, 3.3-67.9). Macroscopically clear CSF was highly indicative (OR, 50.6; 95% CI, 6.2-410.7), as were hydrocephalus (OR, 53.7; 95% CI, 13.4-215.7) and basal meningovascular enhancement (OR, 82.7; 95% CI, 10.5-651.0) on CT scan.
DISCUSSION
In this retrospective assessment, the proposed uniform research case definition [12] provided excellent diagnostic accuracy compared with culture confirmation of TBM, if a "probable" TBM score was used. With a "possible" TBM score, not a single TBM case would have been missed, but clinical utility was minimal given the low specificity achieved. It is important to try and strike an optimal balance between improved sensitivity and adequate specificity given the need to initiate antituberculous therapy as early as possible in all TBM cases.
TBM often presents with nonspecific symptoms in stage I disease, which complicates early diagnosis. Morbidity and mortality increases exponentially with disease progression. Therefore, rapid diagnosis is needed to initiate treatment at the earliest opportunity. Unfortunately, it is difficult to achieve a bacteriologically confirmed diagnosis at this early stage.
Maintaining a high index of suspicion and using a combination of clinical, laboratory, and neuroimaging criteria for early identification of suspected TBM remains essential for early treatment initiation. In 2 previous studies (1 comprising both adults and children and the other comprising only adult patients) comparing TBM and bacterial meningitis, features suggestive of TBM included young age, subacute onset, headache, peripheral white blood cell count, clear CSF appearance, total CSF white cell count, low CSF neutrophil proportion, and elevated CSF protein [13, 16] . Good sensitivities and specificities were obtained both using a composite clinical reference standard and when applied to a microbiologically proven M. tuberculosis reference standard [14] . Our study was limited by absence of data regarding precontrast basal hyperdensity, suggestive CT, magnetic resonance imaging, or ultrasound imaging of tuberculosis outside the central nervous system and positive PCR evidence of extraneural tuberculosis. Precontrast basal hyperdensity was described only in 2004 and was therefore not available [19] . Univariate analysis showed that the majority of criteria were associated with a diagnosis of TBM, which warrants inclusion in the proposed research algorithm [12] . The uniform research TBM case definition needs to be tested robustly in future prospective studies including bacterial meningitis, viral meningitis, and normal CSF control groups, and in both adult and pediatric populations. It should be noted that although some of the TBM data were collected prospectively, all bacterial meningitis data were collected retrospectively.
It is important to appreciate that the proposed research case definition criteria were not designed for use in clinical practice. The normal clinical examination findings in stage I TBM are a limitation of the diagnostic criteria. It would therefore be less likely to score as probable TBM at an earlier stage of disease. The uniform case definition also holds promise for research purposes in resource-constrained settings with limited availability of more sophisticated diagnostic methods until better rapid diagnostic testing becomes available. Larger prospective studies are required where the uniform case definition is robustly tested.
CONCLUSIONS
The proposed uniform TBM research case definition performed well when using a "probable" TBM score to differentiate childhood TBM and bacterial meningitis. Rigorous data collection is essential to obtain the necessary information in all criterion categories and should assist comparability of future prospective studies. However, caution is needed when applying the uniform research case definition to clinical diagnosis of children with early TBM.
